We are live on ! Find out more
CWP

Corepath Wealth Partners Portfolio holdings

AUM $160M
1-Year Est. Return 23.57%
This Fund
S&P 500
This Quarter Est. Return
-1.58%
1 Year Est. Return
+23.57%
3 Year Est. Return
+55.96%
5 Year Est. Return
+46.74%
10 Year Est. Return
–
AUM
$130M
AUM Growth
+$1.07M
Cap. Flow
+$3.97M
Cap. Flow %
3.05%
Top 10 Hldgs %
81.78%
Holding
40
New
2
Increased
16
Reduced
4
Closed
1

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$821K
2
TIP icon
iShares TIPS Bond ETF
TIP
+$579K
3
IUSV icon
iShares Core S&P US Value ETF
IUSV
+$473K
4
LQD icon
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
+$467K
5
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$379K

Top Sells

Rank Stock Value
1
FATE icon
Fate Therapeutics
FATE
+$215K
2
TGT icon
Target
TGT
+$140K
3
CDC icon
VictoryShares US EQ Income Enhanced Volatility Wtd ETF
CDC
+$16K
4
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$5.17K
5
IVW icon
iShares S&P 500 Growth ETF
IVW
+$2.67K

Sector Composition

Rank Sector Weight
1 Technology 0.94%
2 Industrials 0.32%
3 Healthcare 0.22%
4 Consumer Staples 0.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MMM icon
26
3M
MMM
$88.1B
$416K 0.32%
2,794
– –
AOA icon
27
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.19B
$415K 0.32%
5,946
+351
+6% +$25K
NVTA
28
DELISTED
Invitae Corporation
NVTA
$410K 0.31%
15,500
– –
FHLC icon
29
Fidelity MSCI Health Care Index ETF
FHLC
$3.22B
$328K 0.25%
5,189
– –
VXUS icon
30
Vanguard Total International Stock ETF
VXUS
$155B
$306K 0.23%
4,845
– –
JNJ icon
31
Johnson & Johnson
JNJ
$615B
$292K 0.22%
1,827
– –
TGT icon
32
Target
TGT
$62.6B
$278K 0.21%
1,223
-558
-31% -$140K
IWO icon
33
iShares Russell 2000 Growth ETF
IWO
$14.7B
$265K 0.2%
902
– –
VBR icon
34
Vanguard Small-Cap Value ETF
VBR
$37B
$263K 0.2%
1,524
– –
AOR icon
35
iShares Core 60/40 Balanced Allocation ETF
AOR
$3.66B
$248K 0.19%
4,478
+192
+4% +$10.8K
IJR icon
36
iShares Core S&P Small-Cap ETF
IJR
$110B
$245K 0.19%
2,199
-47
-2% -$5.17K
AAPL icon
37
Apple
AAPL
$4.79T
$214K 0.16%
1,517
– –
TLRY icon
38
CALL
Tilray
TLRY
$514M
$16K 0.01%
+2,350
New +$322K
ACB
39
CALL
Aurora Cannabis
ACB
$165M
$13K 0.01%
+2,900
New +$206K
FATE icon
40
Fate Therapeutics
FATE
$301M
– –
-2,250
Closed -$215K
1
2

Similar funds

RB
Robert Bosch Gerlingen Schillerhoehe, Germany $160M AUM 26.69% 1-Year Est. Return
MWM
Mittelman Wealth Management Andover, Massachusetts $160M AUM 13.59% 1-Year Est. Return
CF
CBM Financial Austin, Texas $160M AUM
TA
TPG Advisors Northfield, Illinois $160M AUM 16.16% 1-Year Est. Return
PCC
Perry Creek Capital New York $160M AUM 3.05% 1-Year Est. Return
SGCM
Sanchez Gaunt Capital Management Reno, Nevada $160M AUM
TPW
Turn8 Private Wealth Pointe Claire $160M AUM 25.13% 1-Year Est. Return
RCWM
Royal Capital Wealth Management Carmel, Indiana $161M AUM 18.42% 1-Year Est. Return

Corepath Wealth Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Corepath Wealth Partners held 40 positions worth $130M, up 0.83% from $129M the previous quarter. Its ten largest holdings account for 82% of the portfolio.

Corepath Wealth Partners deployed $3.97M of net new capital in Q3 2021, opening 2 new positions and adding to 16 existing holdings.

By sector, the portfolio is most concentrated in Technology at 0.94% of assets, down from 0.96% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was Target, an estimated $140K trimmed.

  • Corepath Wealth Partners added most to iShares Core S&P 500 ETF in Q3 2021, an estimated $821K increase.
  • Corepath Wealth Partners's biggest Q3 2021 reduction was Target, cutting an estimated $140K.
  • Corepath Wealth Partners fully exited Fate Therapeutics in Q3 2021, selling an estimated $215K.
  • Corepath Wealth Partners's ten largest holdings make up 82% of its $130M portfolio in Q3 2021.
  • Corepath Wealth Partners opened 2 new positions and closed 1 in Q3 2021.
  • Corepath Wealth Partners's portfolio value rose 0.83% quarter-over-quarter to $130M.

Based on Corepath Wealth Partners's 13F filing for Q3 2021, filed 13 Oct 2021.